NantKwest nantkwest.com

NantKwest (NASDAQ: NK), formerly Conkwest, is a life sciences company that is developing and commercializing a robust product pipeline for the treatment of cancers and viral infections. The company's unique natural killer (NK) cell-based platform, with the capacity to grow active killer cells as a biological cancer therapy, has been designed to induce cell death against cancer or infected cells by three different modes of action: (1) Direct killing using activated NK cells (aNK) that release tox...Show all

NantKwest (NASDAQ: NK), formerly Conkwest, is a life sciences company that is developing and commercializing a robust product pipeline for the treatment of cancers and viral infections. The company's unique natural killer (NK) cell-based platform, wi...Show all

See All Exits Recent Exits

Phone: 858-633-0300

Fax:

3530 John Hopkins Court

San Diego, 92121
California, United States

NantKwest - Investments & Acquisitions

Show Real Data NantKwest Investments
See all Recent Investments
Date Company Round Amount Co-investors
2017-04-05Viracta TherapeuticsSeries B - V$18.4MForward Ventures, Latterell Venture Partners, and Wicklow Capital
See all 1 investments